Aficamten may lower symptom burden in non-obstructive hypertrophic cardiomyopathy Presented ByProf. Ahmad Masri, Oregon Health & Science University, OR, USA TrialREDWOOD-HCM ConferenceHFA 2023 TypePeer-reviewed article 8 August 2023 15:52